21 – 30 of 99
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Alzheimer's disease genetic pathways impact cerebrospinal fluid biomarkers and imaging endophenotypes in non-demented individuals
- Contribution to journal › Article
-
Mark
Considerations for widespread implementation of blood-based biomarkers of Alzheimer's disease
- Contribution to journal › Article
-
Mark
Stress testing the Centiloid : Precision and variability of PET quantification of amyloid pathology
- Contribution to journal › Article
-
Mark
Revised criteria for diagnosis and staging of Alzheimer's disease : Alzheimer's Association Workgroup
- Contribution to journal › Article
-
Mark
Personalizing progressive changes to brain structure in Alzheimer's disease using normative modeling
- Contribution to journal › Article
-
Mark
Associations between misfolded alpha-synuclein aggregates and Alzheimer's disease pathology in vivo
- Contribution to journal › Article
-
Mark
In vivo detection of Alzheimer's and Lewy body disease concurrence : Clinical implications and future perspectives
- Contribution to journal › Scientific review
-
Mark
Scenarios for the long-term efficacy of amyloid-targeting therapies in the context of the natural history of Alzheimer's disease
- Contribution to journal › Article
-
Mark
Long-term effects of cholinesterase inhibitors and memantine on cognitive decline, cardiovascular events, and mortality in dementia with Lewy bodies : An up to 10-year follow-up study
- Contribution to journal › Article
-
Mark
CSF glial biomarkers are associated with cognition in individuals at risk of Alzheimer's disease
- Contribution to journal › Article
